OmniAb, Inc. (OABI)
5.11
-0.12
(-2.29%)
USD |
NASDAQ |
Oct 30, 16:00
5.11
0.00 (0.00%)
After-Hours: 20:00
OmniAb Cash from Operations (Quarterly) : 10.58M for Sept. 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 10.58M |
| June 30, 2026 | 2.679M |
| March 31, 2026 | -4.914M |
| December 31, 2025 | -5.674M |
| September 30, 2025 | -9.763M |
| June 30, 2025 | -5.146M |
| March 31, 2025 | -15.87M |
| December 31, 2024 | -3.872M |
| September 30, 2024 | -6.578M |
| June 30, 2024 | -12.18M |
| March 31, 2024 | -17.03M |
| December 31, 2023 | -9.121M |
| Date | Value |
|---|---|
| September 30, 2023 | -6.198M |
| June 30, 2023 | -10.02M |
| March 31, 2023 | 27.69M |
| December 31, 2022 | -7.143M |
| September 30, 2022 | -4.232M |
| June 30, 2022 | -3.852M |
| March 31, 2022 | 11.64M |
| December 31, 2021 | -4.706M |
| September 30, 2021 | -0.9664M |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| IQVIA Holdings, Inc. | 825.00M |
| Champions Oncology, Inc. | -0.492M |
| Medpace Holdings, Inc. | 216.60M |
| Charles River Laboratories International, Inc. | 179.72M |
| Avantor, Inc. | 195.10M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -13.49M |
| Cash from Financing (Quarterly) | 1.458M |
| Free Cash Flow | -18.14M |
| Free Cash Flow Per Share (Quarterly) | 0.0199 |
| Free Cash Flow to Equity (Quarterly) | 3.326M |
| Free Cash Flow to Firm (Quarterly) | 2.569M |
| Free Cash Flow Yield | 0.37% |